Editorial: Proceedings of the “Fourth International Conference of the FMR1 Premutation: Basic Mechanisms, Clinical Involvement and Therapy”

• Karen Usdin,
• Laia Rodriguez-Revenga,
• Rob Willemsen,
• Renate Hukema,
• Cecilia Giulivi,
• Cecilia Giulivi

Affiliations

Karen Usdin

Gene Structure and Disease Section, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States

Laia Rodriguez-Revenga

Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona and CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain

Rob Willemsen

Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands

Renate Hukema

Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands

Cecilia Giulivi

Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States

Cecilia Giulivi

The MIND Institute, University of California, Davis Medical Center, Sacramento, CA, United States